Plus   Neg

NTT 9M Net Profit Up, Operating Profit Down; Backs FY Outlook - Quick Facts

Japan's Nippon Telegraph and Telephone Corp. or NTT (NTT) reported Thursday that its profit attributable to the company for the nine months ended December 31, 2019 increased 0.6 percent to 796.92 billion yen from 792.13 billion yen last year. Earnings per basic share were 214.20 yen, up from 203.25 yen last year.

Operating profit, meanwhile, declined 5 percent to 1.45 trillion yen from 1.53 trillion yen in the prior year.

Operating revenues were 8.86 trillion yen, up 0.8 percent from 8.80 trillion yen last year.

Overseas sales grew 4.8 percent from last year to $14.7 billion. Overseas operating income margin dropped 0.6 percentage points to 2.5 percent.

For the Fiscal Year Ending March 31, 2020, the company continues to expect attributable net profit of 855 billion yen or 231.00 yen per basic share, operating profit of 1.55 trillion yen and operating revenues of 11.89 trillion yen.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT